WC
ABBV icon

Wynn Capital’s AbbVie ABBV Stock Holding History

Wynn Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Buy
9,388
+70
+0.8% +$15.1K 1.05% 30
2026
Q1 		$2.03M Sell
9,318
-44
-0.5% -$9.76K 1.04% 30
2025
Q4 		$2.14M Sell
9,362
-220
-2% -$50.1K 1.04% 27
2025
Q3 		$2.22M Hold
9,582
– – 1.08% 27
2025
Q2 		$1.78M Sell
9,582
-13
-0.1% -$2.42K 0.95% 29
2025
Q1 		$2.01M Buy
9,595
+1,085
+13% +$211K 1.19% 23
2024
Q4 		$1.51M Sell
8,510
-10
-0.1% -$1.84K 0.95% 31
2024
Q3 		$1.68M Buy
8,520
+170
+2% +$31.7K 1.1% 27
2024
Q2 		$1.43M Buy
8,350
+130
+2% +$21.5K 1.06% 29
2024
Q1 		$1.5M Sell
8,220
-204
-2% -$35.2K 1.16% 30
2023
Q4 		$1.31M Buy
+8,424
New +$1.23M 1.07% 31

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wynn Capital's ABBV Position: Q2 2026 in Review

Wynn Capital increased its AbbVie (ABBV) stake by 0.75% in Q2 2026, buying an estimated $15.1K and bringing the position to 9,388 shares worth $2.36M. The position accounts for 1.05% of the portfolio, ranked #30.

Wynn Capital first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,094 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wynn Capital held 9,388 shares of AbbVie worth $2.36M as of Q2 2026.
  • Wynn Capital bought 70 AbbVie shares in Q2 2026, an estimated $15.1K.
  • AbbVie made up 1.05% of Wynn Capital's portfolio in Q2 2026, its #30 holding.
  • Wynn Capital first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 2,094 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wynn Capital's 13F filing for Q2 2026, filed 8 Jul 2026.